# Official Journal C 35/2013

| | ISSN 1977-091X
  doi:10.3000/1977091X.C_2013.035.eng |
| --- | --- |
| Official Journal
  of the European Union | C 35 |
| | |
| English edition | Information and Notices | Volume 567 February 2013 |

ISSN 1977-091X

doi:10.3000/1977091X.C_2013.035.eng

Official Journal

of the European Union

C 35

English edition

Information and Notices

Volume 567 February 2013

---

| Notice No | Contents | page |
| --- | --- | --- |
| | II   Information |
| | INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2013/C 035/01 | Non-opposition to a notified concentration (Case COMP/M.6780 — EVN Netz/OÖ. Ferngas Netz/Gasnetz Steiermark/Gas Connect Austria/Aggm Austrian Gas Grid Management) (
  1
  ) | 1 |
| 2013/C 035/02 | Non-opposition to a notified concentration (Case COMP/M.6799 — Mitsui/Pag/Pag Italy) (
  1
  ) | 1 |

Notice No

Contents

page

II   Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2013/C 035/01

Non-opposition to a notified concentration (Case COMP/M.6780 — EVN Netz/OÖ. Ferngas Netz/Gasnetz Steiermark/Gas Connect Austria/Aggm Austrian Gas Grid Management) (
  1
  )

1

1

2013/C 035/02

Non-opposition to a notified concentration (Case COMP/M.6799 — Mitsui/Pag/Pag Italy) (
  1
  )

1

1

| | IV   Notices |
| --- | --- |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2013/C 035/03 | Euro exchange rates | 2 |

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2013/C 035/03

Euro exchange rates

2

| | V   Announcements |
| --- | --- |
| | PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
| | European Commission |
| 2013/C 035/04 | Prior notification of a concentration (Case COMP/M.6831 — General Motors Company/Parts of Ally Financial) (
  1
  ) | 3 |
| 2013/C 035/05 | Prior notification of a concentration (Case COMP/M.6803 — Avolon/Wells Fargo/ACP JV) — Candidate case for simplified procedure (
  1
  ) | 4 |
| 2013/C 035/06 | Prior notification of a concentration (Case COMP/M.6708 — BMS/Astrazeneca/Amylin Business) — Candidate case for simplified procedure (
  1
  ) | 5 |

V   Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

2013/C 035/04

Prior notification of a concentration (Case COMP/M.6831 — General Motors Company/Parts of Ally Financial) (
  1
  )

1

3

2013/C 035/05

Prior notification of a concentration (Case COMP/M.6803 — Avolon/Wells Fargo/ACP JV) — Candidate case for simplified procedure (
  1
  )

1

4

2013/C 035/06

Prior notification of a concentration (Case COMP/M.6708 — BMS/Astrazeneca/Amylin Business) — Candidate case for simplified procedure (
  1
  )

1

5

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | |
| --- | --- |

EN

---

II Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

| 7.2.2013 | EN | Official Journal of the European Union | C 35/1 |
| --- | --- | --- | --- |

7.2.2013

EN

Official Journal of the European Union

C 35/1

---

Non-opposition to a notified concentration

(Case COMP/M.6780 — EVN Netz/OÖ. Ferngas Netz/Gasnetz Steiermark/Gas Connect Austria/Aggm Austrian Gas Grid Management)

(Text with EEA relevance)

2013/C 35/01

On 29 January 2013, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in German and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32013M6780. EUR-Lex is the on-line access to the European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32013M6780. EUR-Lex is the on-line access to the European law.

---

| 7.2.2013 | EN | Official Journal of the European Union | C 35/1 |
| --- | --- | --- | --- |

7.2.2013

EN

Official Journal of the European Union

C 35/1

---

Non-opposition to a notified concentration

(Case COMP/M.6799 — Mitsui/Pag/Pag Italy)

(Text with EEA relevance)

2013/C 35/02

On 31 January 2013, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32013M6799. EUR-Lex is the on-line access to the European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32013M6799. EUR-Lex is the on-line access to the European law.

---

IV Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

| 7.2.2013 | EN | Official Journal of the European Union | C 35/2 |
| --- | --- | --- | --- |

7.2.2013

EN

Official Journal of the European Union

C 35/2

---

Euro exchange rates (1)

6 February 2013

2013/C 35/03

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,3517 |
| JPY | Japanese yen | 126,48 |
| DKK | Danish krone | 7,4597 |
| GBP | Pound sterling | 0,86310 |
| SEK | Swedish krona | 8,5895 |
| CHF | Swiss franc | 1,2348 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 7,4230 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 25,732 |
| HUF | Hungarian forint | 294,23 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,6999 |
| PLN | Polish zloty | 4,1868 |
| RON | Romanian leu | 4,3895 |
| TRY | Turkish lira | 2,3858 |
| AUD | Australian dollar | 1,3109 |
| CAD | Canadian dollar | 1,3493 |
| HKD | Hong Kong dollar | 10,4814 |
| NZD | New Zealand dollar | 1,6061 |
| SGD | Singapore dollar | 1,6730 |
| KRW | South Korean won | 1 474,24 |
| ZAR | South African rand | 12,0593 |
| CNY | Chinese yuan renminbi | 8,4238 |
| HRK | Croatian kuna | 7,5865 |
| IDR | Indonesian rupiah | 13 117,76 |
| MYR | Malaysian ringgit | 4,1864 |
| PHP | Philippine peso | 54,973 |
| RUB | Russian rouble | 40,5934 |
| THB | Thai baht | 40,267 |
| BRL | Brazilian real | 2,6869 |
| MXN | Mexican peso | 17,1056 |
| INR | Indian rupee | 71,8490 |

Currency

Exchange rate

USD

US dollar

1,3517

JPY

Japanese yen

126,48

DKK

Danish krone

7,4597

GBP

Pound sterling

0,86310

SEK

Swedish krona

8,5895

CHF

Swiss franc

1,2348

ISK

Iceland króna

NOK

Norwegian krone

7,4230

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

25,732

HUF

Hungarian forint

294,23

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,6999

PLN

Polish zloty

4,1868

RON

Romanian leu

4,3895

TRY

Turkish lira

2,3858

AUD

Australian dollar

1,3109

CAD

Canadian dollar

1,3493

HKD

Hong Kong dollar

10,4814

NZD

New Zealand dollar

1,6061

SGD

Singapore dollar

1,6730

KRW

South Korean won

1 474,24

ZAR

South African rand

12,0593

CNY

Chinese yuan renminbi

8,4238

HRK

Croatian kuna

7,5865

IDR

Indonesian rupiah

13 117,76

MYR

Malaysian ringgit

4,1864

PHP

Philippine peso

54,973

RUB

Russian rouble

40,5934

THB

Thai baht

40,267

BRL

Brazilian real

2,6869

MXN

Mexican peso

17,1056

INR

Indian rupee

71,8490

---

(1)  Source: reference exchange rate published by the ECB.

---

V Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

| 7.2.2013 | EN | Official Journal of the European Union | C 35/3 |
| --- | --- | --- | --- |

7.2.2013

EN

Official Journal of the European Union

C 35/3

---

Prior notification of a concentration

(Case COMP/M.6831 — General Motors Company/Parts of Ally Financial)

(Text with EEA relevance)

2013/C 35/04

| 1. | On 29 January 2013, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which General Motors Company (‘General Motors’, US), through its subsidiary General Motors Financial Company Inc. (‘GM Financial’, US) acquires within the meaning of Article 3(1) (b) of the Merger Regulation control of parts of Ally Financial Inc. (‘Ally Financial’, US) by way of purchase of shares in 35 legal entities, active in Europe and Latin America. |
| --- | --- |

1.

On 29 January 2013, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which General Motors Company (‘General Motors’, US), through its subsidiary General Motors Financial Company Inc. (‘GM Financial’, US) acquires within the meaning of Article 3(1) (b) of the Merger Regulation control of parts of Ally Financial Inc. (‘Ally Financial’, US) by way of purchase of shares in 35 legal entities, active in Europe and Latin America.

| 2. | The business activities of the undertakings concerned are:






  — | for General Motors Company: manufacture and supply of motor vehicles worldwide, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for General Motors Company: manufacture and supply of motor vehicles worldwide,

| — | for Ally Financial: supply of automotive financing services, in Europe and Latin America. |
| --- | --- |

—

for Ally Financial: supply of automotive financing services, in Europe and Latin America.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope the EC Merger Regulation. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope the EC Merger Regulation. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6831 — General Motors Company/Parts of Ally Financial, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6831 — General Motors Company/Parts of Ally Financial, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

---

| 7.2.2013 | EN | Official Journal of the European Union | C 35/4 |
| --- | --- | --- | --- |

7.2.2013

EN

Official Journal of the European Union

C 35/4

---

Prior notification of a concentration

(Case COMP/M.6803 — Avolon/Wells Fargo/ACP JV)

Candidate case for simplified procedure

(Text with EEA relevance)

2013/C 35/05

| 1. | On 30 January 2013, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings Avolon Aerospace Leasing Limited (‘Avolon’, Ireland), ultimately controlled by Cinven and Oak Hill, and Wells Fargo Shareholder, a newly created entity ultimately controlled by Wells Fargo & Company (‘Wells Fargo’, the United States) acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the undertaking Avolon Capital Partners Limited (‘ACP’, Ireland) by way of purchase of shares in a newly created company constituting a joint venture. |
| --- | --- |

1.

On 30 January 2013, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings Avolon Aerospace Leasing Limited (‘Avolon’, Ireland), ultimately controlled by Cinven and Oak Hill, and Wells Fargo Shareholder, a newly created entity ultimately controlled by Wells Fargo & Company (‘Wells Fargo’, the United States) acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the undertaking Avolon Capital Partners Limited (‘ACP’, Ireland) by way of purchase of shares in a newly created company constituting a joint venture.

| 2. | The business activities of the undertakings concerned are:






  — | for Avolon: acquisition of aircraft and provision of aircraft operating leasing services, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for Avolon: acquisition of aircraft and provision of aircraft operating leasing services,

| — | for Wells Fargo: provider of banking, insurance, investment, credit card, mortgage, consumer and commercial finance services, |
| --- | --- |

—

for Wells Fargo: provider of banking, insurance, investment, credit card, mortgage, consumer and commercial finance services,

| — | for ACP: acquisition of aircraft and provision of aircraft operating leasing services. |
| --- | --- |

—

for ACP: acquisition of aircraft and provision of aircraft operating leasing services.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6803 — Avolon/Wells Fargo/ACP JV, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6803 — Avolon/Wells Fargo/ACP JV, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

(2)  OJ C 56, 5.3.2005, p. 32 (‘Notice on a simplified procedure’).

---

| 7.2.2013 | EN | Official Journal of the European Union | C 35/5 |
| --- | --- | --- | --- |

7.2.2013

EN

Official Journal of the European Union

C 35/5

---

Prior notification of a concentration

(Case COMP/M.6708 — BMS/Astrazeneca/Amylin Business)

Candidate case for simplified procedure

(Text with EEA relevance)

2013/C 35/06

| 1. | On 28 January 2013, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings Bristol-Myers Squibb Company (‘BMS’, USA) and AstraZeneca Pharmaceuticals LP (‘AZ’, UK) acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of Amylin Collaboration Business (‘Amylin Business’, USA) by way of acquisition of certain governance rights. |
| --- | --- |

1.

On 28 January 2013, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings Bristol-Myers Squibb Company (‘BMS’, USA) and AstraZeneca Pharmaceuticals LP (‘AZ’, UK) acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of Amylin Collaboration Business (‘Amylin Business’, USA) by way of acquisition of certain governance rights.

| 2. | The business activities of the undertakings concerned are:






  — | AZ: primarily engaged in the discovery, development, manufacture and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious diseases, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

AZ: primarily engaged in the discovery, development, manufacture and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious diseases,

| — | BMS: active in the development and commercialization of treatments in several areas, in particular cardiovascular, virology (including HIV infection), oncology, neuroscience, immunoscience, and metabolics treatments, |
| --- | --- |

—

BMS: active in the development and commercialization of treatments in several areas, in particular cardiovascular, virology (including HIV infection), oncology, neuroscience, immunoscience, and metabolics treatments,

| — | Amylin Business: joint development and commercialization of four Amylin compounds, namely exenatide, pramlintide, metreleptin and AC165198. |
| --- | --- |

—

Amylin Business: joint development and commercialization of four Amylin compounds, namely exenatide, pramlintide, metreleptin and AC165198.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6708 — BMS/Astrazeneca/Amylin Business, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6708 — BMS/Astrazeneca/Amylin Business, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

(2)  OJ C 56, 5.3.2005, p. 32 (‘Notice on a simplified procedure’).

---